Publications




Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).
J Neuropathol Exp Neurol 2017 Jul;76(7):605-619
Institute of Neurology, Medical University of Vienna, Vienna, Austria; Center for Neurodegenerative Disease Research, Institute on Aging and Department of Pathology and Laboratory Medicine of the Perelman School of Medicine at the University of Pennsylvania; and Department of Biostatistics and Epidemiology; and Department of Neurosurgery, Center for Brain Injury and Repair, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK; Department of Neuropathology, Institute of Pathology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida; Northwestern University Feinberg School of Medicine, Northwestern ADC Neuropathology Core, Chicago, Illinois; Clinical Neuropathology, King's College Hospital and London Neurodegenerative Brain Bank, London, UK; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland; University of California San Francisco, Institute for Neurodegenerative Diseases, San Francisco, California; Neuropathology Department, Hôpital de La Salpetrière, AP-HP, UPMC-Sorbonne-University, Paris, France; Institute of Neuropathology, Bellvitge University Hospital, University of Barcelona, CIBERNED, Hospitalet de Llobregat, Barcelona, Spain; Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, Australia; Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS, Institut d'Investigacions Biomediques Pi i, Barcelona, Spain; Department of Medicine, Imperial College London, London, UK; IRCCS Foundation "Carlo Besta" Neurological Institute, Milan, Italy; Memory and Aging Center, Department of Neurology, University of California, San Francisco, California; Department of Pathology, University of Sao Paulo Medical School, LIM, São Paulo, Brazil; Brain & Mind Centre, Sydney Medical School, The University of Sydney, and UNSW Medicine & NeuRA, Sydney, Australia; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas; Fishberg Department of Neuroscience, Friedman Brain Institute, and Ronald M. Loeb Center for Alzheimer's Disease, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Neuropathology, John Radcliffe Hospital, Oxford, UK; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Mental Health and Psychiatry, University Hospitals and University of Geneva School of Medicine, Geneva, Switzerland; Institute of Clinical Neurosciences, University of Bristol, Learning & Research Level 2, Southmead Hospital, Bristol, UK; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; Department of Pathology and Molecular Medicine, Thomayer Hospital, Prague, Czech Republic; Department of Pathology, First Medical Faculty, Charles University, Prague, Czech Republic; Department of Anatomical Pathology, Alfred Hospital , Prahran, Victoria, Australia; Division of Pathology, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Pathology and Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky; Physiopathology in Aging Lab/Brazilian Aging Brain Study Group-LIM22, University of Sao Paulo Medical School, Sao Paulo, Brazil; Behavioral and Cognitive Neurology Unit, Department of Neurology, University of São Paulo , São Paulo, Brazil; Netherlands Brainbank, Amsterdam and Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands; Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; Institute of Neuroanatomy, Centre for Biomedicine and Medical Technology Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany; Department of Neurodegenerative Diseases and Gerontopsychiatry at the University of Bonn Medical Center, Bonn, Germany; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan; Department of Neurology, Saitama Medical University International Medical Center, Saitama, Japan; Department of Neuroscience, Katholieke Universiteit-Leuven; and Department of Pathology, Universitaire Ziekenhuizen-Leuven, Leuven, Belgium; Laboratory of Neuropathology, Department of Pathology and Neuropathology, Kepler University Hospital, Medical School, Johannes Kepler University, Linz, Austria; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK; and Department of Pathology and Laboratory Medicine, Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada.

Monitoring urinary orosomucoid in patients undergoing cardiac surgery: A promising novel inflammatory marker.
Clin Biochem 2017 Jul 21. Epub 2017 Jul 21.
Zsigmondy Vilmos Harkány SPA Hospital, 7815 Harkány, Zsigmondy sétány 1, Hungary; Heart Institute, University of Pécs, 7624 Pécs, Ifjúság u. 13, Hungary.

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.
Neurol Neuroimmunol Neuroinflamm 2017 May 14;4(3):e335. Epub 2017 Mar 14.
Department of Neurology (P.K., M.P., H.-J.H., M.M.), Institute of Neuropathology (C.M.), University Hospital Magdeburg; German Center for Neurodegenerative Diseases (DZNE) Magdeburg (P.K.), Germany; Institute of Neurology (M.B., G.G.K., R.H.), Department of Pediatric and Adolescent Medicine (M.B.), Department of Neurology (P.R.), Division of Neuroradiology and Musculoskeletal Radiology (C.M.), Department of Biomedical Imaging and Image-guided Therapy, and Department of Neuroimmunology (H.L.), Center for Brain Research, Medical University of Vienna, Austria; Department of Neuropathology (I.M., W.B.), University Medical Center Göttingen; Leibniz Institute for Neurobiology (H.-J.H.), Magdeburg; Department of Neurology (M.M.), MEDIAN NRZ Flechtingen, Germany; Clinical Department of Neurology (M.R.), Innsbruck Medical University, Austria; Neuroimmunology (K.-P.W., F.L.), Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel/Lübeck; Department of Neurology (K.-P.W.), University Hospital Schleswig-Holstein, Lübeck; and Department of Neurology (F.L.), University Hospital Schleswig-Holstein, Kiel, Germany.

TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
Hum Mutat 2017 Mar 19;38(3):297-309. Epub 2017 Jan 19.
Center for Molecular Neurology, VIB, Antwerp, Belgium.

Secretagogin-dependent matrix metalloprotease-2 release from neurons regulates neuroblast migration.
Proc Natl Acad Sci U S A 2017 Mar 21;114(10):E2006-E2015. Epub 2017 Feb 21.
MTA-SE NAP B Research Group of Experimental Neuroanatomy and Developmental Biology, Hungarian Academy of Sciences, H-1051 Budapest, Hungary;

Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies.
J Neuropathol Exp Neurol 2016 Dec;75(12):1100-1109
From the Department of Pathology and Molecular Medicine, Thomayer Hospital, Prague, Czech Republic (ZR, RM), Institute of Neurology, Medical University of Vienna, Vienna, Austria (IM, MIL, GGK), and Institute of Pathology of the First Faculty of Medicine of Charles University in Prague and General Teaching Hospital, Prague, Czech Republic (RM).



Does exercise pulmonary hypertension exist?
Curr Opin Pulm Med 2016 Sep;22(5):400-7
aDepartment of Respiratory Medicine, Royal Prince Alfred Hospital and Sydney Medical School, University of Sydney, Camperdown, Australia bUniv. Paris-Sud, Faculté de Médecine, INSERM U_999, Le Kremlin Bicêtre, France cAP-HP, Services des Explorations Fonctionnelles, Hôpital Bicêtre, Le Kremlin Bicêtre, France dGreenlane Respiratory Services, Auckland City Hospital, Auckland, New Zealand eDepartment of Internal Medicine, Division of Pulmonology, Medical University of Graz, Ludwig Boltzmann Institute of Lung Vascular Research, Graz, Austria fDépartement de Chirurgie Thoracique, Vasculaire et de Transplantation Pulmonaire, Hôpital Marie Lannelongue, Le Plessis Robinson gFrench Referral Centre for Pulmonary Hypertension, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.


Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group.
J Clin Oncol 2016 Aug 29. Epub 2016 Aug 29.
Gabor Kovacs, Sandra Robrecht, Anna Maria Fink, Jasmin Bahlo, Paula Cramer, Julia von Tresckow, Christian Maurer, Petra Langerbeins, Kirsten Fischer, Michael Hallek, and Barbara Eichhorst, University of Cologne and Center of Integrated Oncology Cologne/Bonn, Cologne; Matthias Ritgen, Michael Kneba, and Sebastian Böttcher, University of Schleswig-Holstein, Lubeck; Hartmut Döhner and Stephan Stilgenbauer, University of Ulm, Ulm; Wolfram Klapper, University of Kiel, Kiel; Clemens-Martin Wendtner, Klinikum Schwabing, Munich, Germany; and Günter Fingerle-Rowson, F. Hoffmann La-Roche, Basel, Switzerland.







Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.
Circulation 2016 Mar 29;133(9):859-71. Epub 2016 Jan 29.
From KU Leuven - University of Leuven, University Hospitals of Leuven, Belgium (M.D.); Medical University of Vienna, Austria (I.L.); Papworth Hospital, Cambridge, United Kingdom (J.P.-Z., C.T., D.J.); Clinical Department of Cardiology and Angiology of the First Faculty of Medicine and General Teaching Hospital, Prague; Czech Republic (P.J., D.A., J.L.); San Matteo Hospital, University of Pavia, Italy (A.M.D., M.M.); St Antonius Ziekenhuis, Nieuwegein, The Netherlands (R.S.); OLVG, Amsterdam, The Netherlands (P.B.); Medical Center for Postgraduate Education, ECZ-Otwock, Poland (A.T.); Aarhus University Hospital, Skejby, Denmark (S.M.); Regional Specialist Hospital and Medical University, Wroclaw, Poland (J.L.); Slovak Medical University and National Institute of Cardiovascular Diseases, Bratislava, Slovakia (I.S.); Hospital Clínic- IDIBAPS-CIBER Enfermedades Respiratorias, Universtiy of Barcelona, Spain (J.A.B.); Toronto General Hospital, Canada (M.d.P.); Medizinische Hochschule Hannover, Germany, and German Center of Lung Research (DZL), Hannover, Germany (M.M.H.); Mater Misericordiae University Hospital, Dublin, Ireland (S.G.); Universitätspital Zürich, Switzerland (R.S.); Hospital Universitario 12 Octubre-CIBER Enfermedades Respiratorias, Madrid, Spain (M.A.G.-S.); Medical University of Graz, Austria and Ludwig Boltzmann Institute for Lung Vascular Research, Austria (G.K.); University Paris Sud (Paris XI), INSERM U 999, Hôpital Le Kremlin Bicêtre, France (X.J., P.D., G.S.); and Kerckhoff Heart and Lung Center, Bad Nauheim, Germany (E.M.).

Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
Acta Neuropathol Commun 2016 Mar 8;4:24. Epub 2016 Mar 8.
Division of Molecular Psychiatry, University Medical Center (UMG), Georg-August-University, Göttingen, Germany.

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial.
Blood 2016 Jan 20;127(2):208-15. Epub 2015 Oct 20.
Department I for Internal Medicine and Center of Integrated Oncology, University of Cologne, Cologne, Germany; Cluster of Excellence Cellular Stress Responses in Aging Associated Diseases, University of Cologne, Cologne, Germany.


[Long-term follow-up of patients with transposition of the great arteries following Senning or Mustard operations. Results from the CSONGRAD Registry].
Orv Hetil 2016 Jan;157(3):104-10
II. Belgyógyászati Klinika és Kardiológiai Központ, Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szent-Györgyi Albert Klinikai Központ Szeged, Korányi fasor 6., 6720.

Genetic Creutzfeldt-Jakob disease mimicking chronic inflammatory demyelinating polyneuropathy.
Neurol Neuroimmunol Neuroinflamm 2015 Dec 29;2(6):e173. Epub 2015 Oct 29.
Departments of Neurology (D.W., M.S., P.V.D.), Radiology (P.D.), and Pathology (T.T.), University Hospitals Leuven; KU Leuven (M.S.), University of Leuven, Department of Neurosciences, Experimental Neurology, Laboratory for Cognitive Neurology, Leuven; Neurodegenerative Brain Diseases Group (C.V.B.), Department of Molecular Genetics, VIB, Antwerp; Laboratory of Neurogenetics (C.V.B.), Institute Born-Bunge, University of Antwerp, Belgium; Institute of Neurology (G.G.K.), Medical University of Vienna, Austria; KU Leuven (P.V.D.), University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease, Leuven; and VIB (P.V.D.), Vesalius Research Center, Laboratory of Neurobiology, Leuven, Belgium.



Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity.
PLoS One 2015 12;10(10):e0140136. Epub 2015 Oct 12.
2nd Department of Paediatrics, Semmelweis University, Budapest, Hungary; Central Laboratory, Heim Pal Children Hospital, Budapest, Hungary.

Loss-of-Function Variants in a Hungarian Cohort Reveal Structural Insights on TSH Receptor Maturation and Signaling.
J Clin Endocrinol Metab 2015 Jul 15;100(7):E1039-45. Epub 2015 May 15.
Department of Laboratory Medicine (A.L., O.R., A.M., G.L.K.), University of Pécs, 7624 Pécs, Hungary; Department of Clinical Sciences and Community Health (E.S.G., L.P.), University of Milan, 20122 Milan, Italy; Department of Pediatrics and Pediatric Health Care Center (B.G.), University of Szeged, 6720 Szeged, Hungary; Institute of Experimental Pediatric Endocrinology (G.K., H.B.), Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; First Department of Internal Medicine (B.R., E.M.), University of Pécs, 7624 Pécs, Hungary; Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research (G.G., L.P.), Ospedale San Luca, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Auxologico Italiano, 20149 Milan, Italy; Szentágothai Research Centre (G.L.K.), University of Pécs, 7624 Pécs, Hungary; HAS-SE "Lendület" Hereditary Endocrine Tumors Research Group (A.P.), 1085 Budapest, Hungary; and Departments of Pediatrics (E.F.) and Internal Medicine (E.V.N.), Faculty of Medicine, University of Debrecen, 4032 Debrecen Hungary.


[More than 50 years' experience in the treatment of patients with congenital heart disease at a Hungarian university hospital].
Orv Hetil 2015 May;156(20):794-800
II. Belgyógyászati Klinika és Kardiológiai Központ, Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szent-Györgyi Albert Klinikai Központ Szeged, Semmelweis u. 6., 6725.


OF